The problem is the 2 drugs that have completed Phase II they have been unable to find anybody that's wants to license them for a very long time ….. despite great (?) data ?
1102 for MS - Teva handed back almost 10 years ago after Phase II completion …
Got another shot with TJAB striking a deal few years later but they too handed it back.
1103 for Acromegaly - Cortendo licensed it on Phase II data almost 5 years ago and then handed it back not long after.
It's all about DMD and hopefully achieving better outcomes over the next few years when they get to a Phase IIb trial.
- Forums
- ASX - By Stock
- PER
- Two drugs in phase 2 and one in Phase 2b
Two drugs in phase 2 and one in Phase 2b, page-2
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.8¢ |
Change
-0.001(0.64%) |
Mkt cap ! $69.86M |
Open | High | Low | Value | Volume |
7.8¢ | 7.9¢ | 7.8¢ | $1.882K | 24.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6454 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 125752 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6454 | 0.077 |
2 | 84859 | 0.076 |
5 | 206544 | 0.075 |
4 | 420708 | 0.074 |
1 | 100000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 125752 | 3 |
0.080 | 203231 | 1 |
0.081 | 150000 | 2 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
Last trade - 13.43pm 23/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online